Lipocell is the first atraumatic autologous adipose tissue purification system patented at the European level. The device boasts six scientific publications and has been used in over 20,000 procedures in the last five years.
Lipocell ensures “gentle” processing, preserving the vascular-stromal niches, the entire extracellular matrix, and all the mechanical and regenerative capabilities of the autologous tissue.
WHY choose LIPOCELL
Current solutions pose risks of contamination and reduced short- and medium-term efficacy of the treatment, due to the limited amount of harvested tissue and the processing methods, which often involve only micro-fragmentation within a syringe.
This process fails to effectively remove oils and blood residues, which may cause inflammation.
The device is supported by six scientific publications and has been used in over 20,000 procedures over the past five years.
what is LIPOCELL
Autologous adipose tissue is rich in mesenchymal cells, also known as adult stem cells. Mesenchymal cells have the ability to differentiate into various cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), and connective tissue cells. This capability promotes the regeneration of damaged joint tissues.
the european patent
The Lipocell system is the only one on the market to have obtained both an Italian and a European patent as a closed-circuit system with a tubular filter.
The Lipocell patent was developed to provide a “gentle” washing of adipose tissue, preserving its structure and maintaining both its mechanical properties and filling capacity.